Locus Cell Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1.04	0.41	0.6	-	-
Revenue Growth (YoY)	73.33%	-32.33%	-	-	-
Cost of Revenue	0.65	0.24	0.1	-	-
Gross Profit	0.39	0.17	0.5	-	-
Selling, General & Admin	84.4	79.19	60.67	31.82	0.25
Research & Development	71.38	61.41	31.97	1.7	-
Operating Expenses	155.78	140.6	92.64	33.52	0.25
Operating Income	-155.39	-140.43	-92.14	-33.52	-0.25
Interest Expense	-1.26	-1.28	-1.32	-1.09	-
Interest & Investment Income	33.25	36.3	11.63	0.74	-
Currency Exchange Gain (Loss)	14.01	6.36	27.62	-0.64	-
Other Non Operating Income (Expenses)	0.07	2.16	0.74	-	-
Pretax Income	-109.33	-96.89	-53.48	-34.52	-0.25
Net Income	-109.33	-96.89	-53.48	-34.52	-0.25
Net Income to Common	-109.33	-96.89	-53.48	-34.52	-0.25
Shares Outstanding (Basic)	200	200	200	127	0
Shares Outstanding (Diluted)	200	200	200	127	0
Shares Change (YoY)	-	-	57.96%	126512.00%	-
EPS (Basic)	-0.55	-0.48	-0.27	-0.27	-2.52
EPS (Diluted)	-0.55	-0.48	-0.27	-0.27	-2.52
Free Cash Flow	-396.32	-158.87	-62.12	-30.22	-
Free Cash Flow Per Share	-1.98	-0.79	-0.31	-0.24	-
Gross Margin	37.21%	42.12%	83.17%	-	-
Operating Margin	-14941.73%	-34588.18%	-15357.17%	-	-
Profit Margin	-10512.40%	-23865.52%	-8913.00%	-	-
Free Cash Flow Margin	-38107.40%	-39131.53%	-10352.50%	-	-
EBITDA	-149.01	-136.48	-91.25	-33.36	-
D&A For EBITDA	6.38	3.95	0.89	0.16	-
EBIT	-155.39	-140.43	-92.14	-33.52	-0.25

Source: S&P Capital IQ. Standard template. Financial Sources.